Healthcare · Biotechnology

Is Lakewood-Amedex Biotherapeutics, Inc. (LABT) Stock Halal?

Shariah Compliance Across 5 Standards — Live

NON-COMPLIANTMarket cap $5.2M
Screened 2026-08-24Halal Terminal screening engineSource: latest public financial filings
Live screening

Screen LABT live and build a compliant portfolio

Live verdicts across 5 Shariah standards, financial ratios, segment-level business income, purification and Zakat — one workspace, always current.

Screen LABT live

Shariah Compliance Verdict — 5 Standards

AAOIFI (Shari'ah Standard 21)market-cap basis

cash/MC 88.8% > 30%

NON-COMPLIANT

Dow Jones Islamic Marketmarket-cap basis

missing: debt_ratio, interest_ratio

UNDER REVIEW

FTSE Shariah (Yasaar)total-assets basis

cash/assets 92.4% > 33%

NON-COMPLIANT

MSCI Islamictotal-assets basis

cash/assets 92.4% > 33%

NON-COMPLIANT

S&P Shariahmarket-cap basis

missing: debt_ratio, interest_ratio

UNDER REVIEW

Live verdicts from the Halal Terminal screening engine, recomputed against the issuer's latest filings.

Plain-English Summary

Fails AAOIFI, FTSE, MSCI on cash/MC 88.8% > AAOIFI 30%; cash/assets 92.4% > FTSE 33%, MSCI 33%. DJIM, S&P insufficient data (missing: debt_ratio, interest_ratio).

Business Activity Screen

Business activity is compliant.

Financial Ratios

Cash & interest-bearing / market cap

AAOIFI ≤30% of market cap

88.8%

Cash & interest-bearing / total assets

FTSE/MSCI <33.33% of total assets

92.4%

Raw ratios from the latest filings — each methodology applies its own basis and thresholds (see the verdict box above for per-standard outcomes).

Balance-Sheet Trajectory (3 Quarters)

Quarter endDebt / assetsCash / assetsReceivables + cash / assets
2025-12-3149.1%49.1%
2026-03-316.0%6.0%
2026-06-3092.4%92.4%

A stock that has screened comfortably for eight straight quarters is a different story from one that crossed a threshold last quarter — trajectory shows which one this is.

Frequently Asked Questions

Is Lakewood-Amedex Biotherapeutics, Inc. (LABT) halal to invest in?

Lakewood-Amedex Biotherapeutics, Inc. currently screens as non-compliant on the Halal Terminal engine. The verdict is recomputed against the issuer's latest financial filings and all five major methodologies (AAOIFI, DJIM, FTSE, MSCI, S&P) — see the per-standard breakdown above. This is a data-driven application of published standards, not a fatwa.

Is LABT compliant under AAOIFI?

No — LABT currently fails AAOIFI screening: cash/MC 88.8% > 30%.

Do I need to purify dividends from LABT?

A purification rate could not be computed from the latest filings; consult the methodology page for how purification works.

Why do halal screening apps disagree about LABT?

Different services apply different ratio bases (market capitalization vs total assets), different revenue classifications, and different data vintages. This page shows both AAOIFI readings side by side and classifies revenue segments explicitly so the source of any disagreement is visible.

All Healthcare
Live screening

Screen your full portfolio, not just one stock

Live verdicts across 5 Shariah standards, financial ratios, segment-level business income, purification and Zakat — one workspace, always current.

Screen LABT live

Disclaimer: This page is for educational and informational purposes only and does not constitute financial or religious advice. Verdicts and figures come from the Halal Terminal screening engine, computed from the issuer's public financial filings and refreshed regularly (last screened 2026-08-24). This is a data-driven application of published Shariah standards — not a fatwa. Consult a qualified Islamic finance scholar or advisor for personalised guidance.